Lei Meng

Insider Reports History

Location
New York, NY
Signature
LEI MENG, /s/ Adam Veness, as attorney-in-fact for Lei Meng
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lei Meng:

Company Role Class Num Shares Value Price $ Report Date Ownership
Dianthus Therapeutics, Inc. /DE/ Director Common Stock 2,717,554 $32,610,648 $12 22 Jan 2024 Indirect
Dianthus Therapeutics, Inc. /DE/ Director Pre-Funded Warrants (Right to Buy) 1,833,333 $21,998,163 $12 22 Jan 2024 Indirect
Dianthus Therapeutics, Inc. /DE/ Director Stock Option (Right to Buy) 6,500 11 Sep 2023 Indirect

Insider Reports Filed by Lei Meng

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DNTH Dianthus Therapeutics, Inc. /DE/ 22 Jan 2024 2 $39,998,162 4 Director 24 Jan 2024, 18:55
MGTA Dianthus Therapeutics, Inc. /DE/ 11 Sep 2023 1 $0 4 Director 13 Sep 2023, 21:56
MGTA Dianthus Therapeutics, Inc. /DE/ 11 Sep 2023 0 $0 3 Director 13 Sep 2023, 21:31